HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Viramune (Nevirapine)

The Basics | News | Research

Show Archived (Historical) Articles

Brand Name:	Viramune
Generic Name:	Nevirapine, NVP
Adult Single Dose:	One 200-mg tablet (once a day) for 14 days then one 200-mg tablet (twice a day)
Food & Liquid Restrictions:	None
Drug Class:	NNRTI

The Basics

An Overview of Viramune (Nevirapine) (Regularly Updated)
To read PDF, click here.
From U.S. National Institutes of Health
Nevirapine (Viramune) (October 10, 2009)
To read PDF, click here.
From AIDS InfoNet
Viramune (March/April 2009)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
Patient Information About Viramune (Nevirapine) (PDF) (November 2008)
From Boehringer Ingelheim
Viramune (Nevirapine) (September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs

News

New Assistance Program Helps HIVers Pay for Viramune (October 7, 2009)
From The Body
FDA Public Health Advisory for Nevirapine (Viramune) (January 19, 2005)
From U.S. Food and Drug Administration

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.